vs
ANGIODYNAMICS INC（ANGO）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
ANGIODYNAMICS INC的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的1.1倍（$79.4M vs $70.9M），RCI HOSPITALITY HOLDINGS, INC.净利率更高（-7.8% vs -8.0%，领先0.2%），ANGIODYNAMICS INC同比增速更快（9.0% vs -3.1%），RCI HOSPITALITY HOLDINGS, INC.自由现金流更多（$11.5M vs $4.2M），过去两年ANGIODYNAMICS INC的营收复合增速更高（2.8% vs -2.0%）
AngioDynamics是一家全球医疗技术企业，专注于研发、生产及销售微创医疗设备，核心产品覆盖血管通路、外科消融、肿瘤治疗等领域，面向北美、欧洲、亚太地区的医院、门诊手术中心及各类医疗机构提供服务。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
ANGO vs RICK — 直观对比
营收规模更大
ANGO
是对方的1.1倍
$70.9M
营收增速更快
ANGO
高出12.2%
-3.1%
净利率更高
RICK
高出0.2%
-8.0%
自由现金流更多
RICK
多$7.3M
$4.2M
两年增速更快
ANGO
近两年复合增速
-2.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $70.9M |
| 净利润 | $-6.3M | $-5.5M |
| 毛利率 | 56.4% | — |
| 营业利润率 | -7.7% | -0.7% |
| 净利率 | -8.0% | -7.8% |
| 营收同比 | 9.0% | -3.1% |
| 净利润同比 | 40.9% | -2354.9% |
| 每股收益（稀释后） | $-0.15 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANGORICK
| Q4 25 | $79.4M | — | ||
| Q3 25 | $75.7M | $70.9M | ||
| Q2 25 | $80.2M | $71.1M | ||
| Q1 25 | $72.0M | $65.9M | ||
| Q4 24 | $72.8M | $71.5M | ||
| Q3 24 | $67.5M | $73.2M | ||
| Q2 24 | $71.0M | $76.2M | ||
| Q1 24 | $75.2M | $72.3M |
净利润ANGORICK
| Q4 25 | $-6.3M | — | ||
| Q3 25 | $-10.9M | $-5.5M | ||
| Q2 25 | $-6.0M | $4.1M | ||
| Q1 25 | $-4.4M | $3.2M | ||
| Q4 24 | $-10.7M | $9.0M | ||
| Q3 24 | $-12.8M | $244.0K | ||
| Q2 24 | $-13.4M | $-5.2M | ||
| Q1 24 | $-187.7M | $774.0K |
毛利率ANGORICK
| Q4 25 | 56.4% | — | ||
| Q3 25 | 55.3% | — | ||
| Q2 25 | 52.7% | — | ||
| Q1 25 | 54.0% | — | ||
| Q4 24 | 54.8% | — | ||
| Q3 24 | 54.4% | — | ||
| Q2 24 | 54.3% | — | ||
| Q1 24 | 47.7% | — |
营业利润率ANGORICK
| Q4 25 | -7.7% | — | ||
| Q3 25 | -14.1% | -0.7% | ||
| Q2 25 | -7.2% | 12.2% | ||
| Q1 25 | -13.9% | 12.4% | ||
| Q4 24 | -15.2% | 19.5% | ||
| Q3 24 | -19.4% | 4.8% | ||
| Q2 24 | -20.4% | -3.3% | ||
| Q1 24 | -265.9% | 6.4% |
净利率ANGORICK
| Q4 25 | -8.0% | — | ||
| Q3 25 | -14.4% | -7.8% | ||
| Q2 25 | -7.5% | 5.7% | ||
| Q1 25 | -6.1% | 4.9% | ||
| Q4 24 | -14.7% | 12.6% | ||
| Q3 24 | -19.0% | 0.3% | ||
| Q2 24 | -18.9% | -6.9% | ||
| Q1 24 | -249.7% | 1.1% |
每股收益（稀释后）ANGORICK
| Q4 25 | $-0.15 | — | ||
| Q3 25 | $-0.26 | $-0.60 | ||
| Q2 25 | $-0.15 | $0.46 | ||
| Q1 25 | $-0.11 | $0.36 | ||
| Q4 24 | $-0.26 | $1.01 | ||
| Q3 24 | $-0.31 | $0.04 | ||
| Q2 24 | $-0.35 | $-0.56 | ||
| Q1 24 | $-4.67 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.6M | $33.7M |
| 总债务越低越好 | — | $238.2M |
| 股东权益账面价值 | $176.3M | $261.1M |
| 总资产 | $269.7M | $596.9M |
| 负债/权益比越低杠杆越低 | — | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资ANGORICK
| Q4 25 | $41.6M | — | ||
| Q3 25 | $38.8M | $33.7M | ||
| Q2 25 | $55.9M | $29.3M | ||
| Q1 25 | $44.8M | $32.7M | ||
| Q4 24 | $54.1M | $34.7M | ||
| Q3 24 | $55.0M | $32.4M | ||
| Q2 24 | $76.1M | $34.9M | ||
| Q1 24 | $78.5M | $20.0M |
总债务ANGORICK
| Q4 25 | — | — | ||
| Q3 25 | — | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | $0 | — | ||
| Q1 24 | — | — |
股东权益ANGORICK
| Q4 25 | $176.3M | — | ||
| Q3 25 | $178.9M | $261.1M | ||
| Q2 25 | $183.0M | $269.5M | ||
| Q1 25 | $185.9M | $268.8M | ||
| Q4 24 | $186.8M | $269.0M | ||
| Q3 24 | $196.6M | $263.4M | ||
| Q2 24 | $205.6M | $271.2M | ||
| Q1 24 | $218.7M | $285.8M |
总资产ANGORICK
| Q4 25 | $269.7M | — | ||
| Q3 25 | $265.6M | $596.9M | ||
| Q2 25 | $280.1M | $597.4M | ||
| Q1 25 | $285.4M | $589.8M | ||
| Q4 24 | $291.6M | $586.2M | ||
| Q3 24 | $293.6M | $584.4M | ||
| Q2 24 | $317.7M | $601.0M | ||
| Q1 24 | $324.8M | $609.9M |
负债/权益比ANGORICK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.7M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $4.2M | $11.5M |
| 自由现金流率自由现金流/营收 | 5.3% | 16.2% |
| 资本支出强度资本支出/营收 | 0.5% | 3.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-9.3M | $34.9M |
8季度趋势，按日历期对齐
经营现金流ANGORICK
| Q4 25 | $4.7M | — | ||
| Q3 25 | $-15.9M | $13.7M | ||
| Q2 25 | $18.8M | $13.8M | ||
| Q1 25 | $-13.2M | $8.5M | ||
| Q4 24 | $2.5M | $13.3M | ||
| Q3 24 | $-18.3M | $15.7M | ||
| Q2 24 | $5.0M | $15.8M | ||
| Q1 24 | $-12.5M | $10.8M |
自由现金流ANGORICK
| Q4 25 | $4.2M | — | ||
| Q3 25 | $-16.6M | $11.5M | ||
| Q2 25 | $18.0M | $10.1M | ||
| Q1 25 | $-15.0M | $5.7M | ||
| Q4 24 | $1.7M | $7.6M | ||
| Q3 24 | $-19.3M | $10.3M | ||
| Q2 24 | $4.4M | $9.3M | ||
| Q1 24 | $-13.1M | $3.2M |
自由现金流率ANGORICK
| Q4 25 | 5.3% | — | ||
| Q3 25 | -22.0% | 16.2% | ||
| Q2 25 | 22.5% | 14.2% | ||
| Q1 25 | -20.8% | 8.6% | ||
| Q4 24 | 2.3% | 10.6% | ||
| Q3 24 | -28.7% | 14.0% | ||
| Q2 24 | 6.2% | 12.3% | ||
| Q1 24 | -17.5% | 4.4% |
资本支出强度ANGORICK
| Q4 25 | 0.5% | — | ||
| Q3 25 | 1.0% | 3.2% | ||
| Q2 25 | 1.0% | 5.2% | ||
| Q1 25 | 2.5% | 4.3% | ||
| Q4 24 | 1.1% | 8.0% | ||
| Q3 24 | 1.6% | 7.3% | ||
| Q2 24 | 0.8% | 8.4% | ||
| Q1 24 | 0.8% | 10.6% |
现金转化率ANGORICK
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.40× | ||
| Q1 25 | — | 2.65× | ||
| Q4 24 | — | 1.48× | ||
| Q3 24 | — | 64.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ANGO
| Med Device | $37.2M | 47% |
| Med Tech | $30.4M | 38% |
| Other | $11.8M | 15% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
